What are the side effects of the combination Avmapki and Faczynja?

When the combination of Avmapki and Faczynja was used to treat KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC), patients experienced a variety of side effects in clinical studies, and the occurrence of these adverse reactions had a certain impact on the patients' daily life and overall health status. First, nausea and vomiting are one of the most common adverse reactions, which may cause patients to lose appetite, thereby affecting nutritional intake and weight maintenance. At the same time, increased fatigue makes it difficult for patients to maintain a normal pace of life during treatment and often requires more rest time.

Rashes and acneiform dermatitis are also significant side effects of this combination. Patients may experience varying degrees of skin damage, which in severe cases may affect their psychological state and lead to a decrease in self-confidence. In addition, digestive system reactions such as diarrhea and abdominal pain are equally disturbing and may affect patients' eating habits and quality of life. Musculoskeletal pain, joint pain, etc. have also been reported as one of the common reactions, which undoubtedly increases the burden of life for patients who are already frail.

In laboratory tests, many patients show abnormal changes in blood indicators. For example, elevated creatine phosphokinase is associated with rhabdomyolysis, where muscle and motor function are affected. Increases in liver function indicators such as aspartate aminotransferase and alanine aminotransferase indicate possible liver toxicity, which requires doctors to closely monitor the patient's liver function during treatment. At the same time, phenomena such as reduced lymphocyte count and reduced platelet count also make patients more susceptible to infection and increase the risk of complications.

In terms of more serious warnings and precautions, eye toxicity may result in visual impairment, while hepatotoxicity requires prompt intervention to prevent more serious consequences. Embryo-The issue of fetal toxicity is particularly important for female patients planning to become pregnant and needs to be fully informed and evaluated before treatment.

Reference materials:https://www.drugs.com/history/avmapki-faczynja-co-pack.html